Balance Sheet Data
ReShape Lifesciences Inc. (RSLS)
$0.2281
-0.02 (-8.72%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 5.55 | 2.94 | 2.96 | 22.76 | 3.86 | 180.52 | 1,247.77 | 8,624.97 | 59,618.29 | 412,098.62 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.92 | 4.10 | 2.62 | 2.81 | 2.18 | 37.53 | 259.43 | 1,793.28 | 12,395.69 | 85,682.56 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.98 | 1.32 | 2.24 | 3 | 3.61 | 38.09 | 263.26 | 1,819.74 | 12,578.58 | 86,946.72 |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.63 | 4.26 | 3.65 | 3.47 | 1.93 | 57.70 | 398.85 | 2,756.94 | 19,056.75 | 131,725.67 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.05 | -0.01 | -0.39 | -0.35 | -0.13 | -2.40 | -16.62 | -114.85 | -793.91 | -5,487.73 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.